<DOC>
	<DOC>NCT01444274</DOC>
	<brief_summary>This will be an observational, prospective, non-randomized, pilot study to gain initial device experience on a novel space-occupying device in persons who are overweight or obese. No formal hypothesis testing will be conducted.</brief_summary>
	<brief_title>Pilot Study to Evaluate A Novel Gastric Space Occupying Device</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<criteria>1. Age between 2164 years 2. BMI 2740 Kg/m2 3. No history of weight reduction of more than 5% of total body weight in the past 6 months 1. Have unstable angina, myocardial infarction within the past year, or heart disease classified within the New York Heart Association's Class III or IV functional capacity; 2. Be taking chronic aspirin or other non steroidal antiinflammatory agents, or other medications known to be gastric irritants, and unwillingness to discontinue the use of these concomitant medications, antiarrythmics, antianginal medications, anticoagulants or medications for congestive heart failure; 3. Be taking blood pressure medications, unless their blood pressure is controlled and they have been at stable dose for at least 3 months; 4. Have type 1 diabetes or type 2 diabetes requiring oral medications or insulin; 5. History or symptoms of thyroid disease which is not controlled by medication; 6. Have severe renal, hepatic, pulmonary disease or cancer; 7. Past history of gastrointestinal surgery (excluding uncomplicated appendectomy); 8. Have a history of adhesive peritonitis; 9. History or symptoms of esophageal and/or gastric varices; 10. Have history or congenital or acquired GI anomalies (e.g. atresias, stricture, and /or diverticula); 11. History or symptoms of inflammatory bowel disease, such as Chron's disease; 12. History of/ signs and /or symptoms of duodenal or gastric ulcer; 13. Have gastroparesis; 14. Pregnant or breastfeeding or intention of becoming pregnant during the study (if female of childbearing potential); 15. Currently using pharmaceutical agents for weight loss;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>